Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Adial Pharmaceuticals Inc (NQ: ADIL )

0.9499 +0.0019 (+0.20%)
Streaming Delayed Price Updated: 3:59 PM EDT, Oct 9, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Adial Pharmaceuticals Inc

< Previous 1 2 3 4 5 6 Next >
S&P 500 Down 1%; Delta Air Lines Posts Upbeat Earnings
U.S. stocks traded lower toward the end of trading, with the S&P 500 falling around 1% on Wednesday. The Dow traded down 1.15% to 38,438.09 while the NASDAQ fell 0.89% to 16,162.29. The S&P 500 also... 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Ascent Solar Technologies Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Ascent Solar Technologies, Inc. (NASDAQ: ASTI) fell sharply during Wednesday’s session after the company announced pricing of a $6 million public offering of shares at $0.14 per share. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Peering Into Adial Pharmaceuticals's Recent Short Interest
Via Benzinga
Crude Oil Edges Higher; Marin Software Shares Jump
U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 500 points on Wednesday. The Dow traded down 1.30% to 38,376.37 while the NASDAQ fell 1.11% to 16,126.44. The... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Why Is Adial Pharmaceuticals (ADIL) Stock Up 59% Today?
Adial Pharmaceuticals stock is up on Wednesday with heavy trading of ADIL shares alongside positive coverage of its AUD treatment. 
Via InvestorPlace
Dow Falls Over 1%; US Inflation Rate Accelerates In March
U.S. stocks traded lower this morning, with the Dow Jones index falling more than 1% on Wednesday. Following the market opening Wednesday, the Dow traded down 1.21% to 38,414.32 while the NASDAQ fell... 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
EXCLUSIVE: Adial Pharmaceuticals' Potential Treatment For Alcohol Use Disorder Shows Encouraging Safety, Patient Compliance
Adial Pharmaceuticals releases a peer-reviewed article on AD04, its lead investigational drug for Alcohol Use Disorder. The study highlights a strong safety profile & liver safety compared to a... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Why Cardlytics Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket
Shares of Cardlytics, Inc. (NASDAQ: CDLX) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter earnings. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why BioVie Shares Are Trading Lower By Around 42%; Here Are 20 Stocks Moving Premarket
Shares of BioVie Inc. (NASDAQ: BIVI) fell sharply in today’s pre-market trading after the company reported pricing of public offering. BioVie shares dipped 41.8% to $1.10 in pre-market trading Here are... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
We're starting off the trading week with a breakdown of all the biggest pre-market stock movers worth watching on Monday morning! 
Via InvestorPlace
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Zscaler, Inc. (NASDAQ: ZS) shares fell sharply during Friday’s session following second-quarter results. 
Via Benzinga
US Stocks Mixed; Dell Posts Upbeat Results
U.S. stocks traded mixed this morning, with the Dow Jones falling around 40 points on Friday. Following the market opening Friday, the Dow traded down 0.11% to 38,954.76 while the NASDAQ rose 0.11% to... 
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results. 
Via Benzinga
Why Adial Pharmaceuticals Stock Is Blasting Off
Adial Pharmaceuticals said the patent was awarded by the United States Patent and Trademark Office on Feb. 20 and covers the company's lead investigational new drug product, AD04, and its ability to... 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
S&P 500 Edges Lower; ADT Posts Upbeat Earnings
U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling around 100 points on Wednesday. The Dow traded down 0.27% to 38,867.91 while the NASDAQ fell 0.50% to 15,954.75. The... 
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Nasdaq Down 50 Points; US Crude Stocks Rise By 4.2M Barrels
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 50 points on Wednesday. The Dow traded down 0.19% to 38,899.92 while the NASDAQ fell 0.31% to 15,985.25. The... 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results. 
Via Benzinga
Dow Dips 200 Points; TJX Posts Upbeat Sales
U.S. stocks traded lower this morning, with the Dow Jones index falling around 200 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.52% to 38,770.83 while the NASDAQ... 
Via Benzinga
Topics Stocks
Exposures US Equities
EXCLUSIVE: Adial Pharmaceuticals Secures New US Patent Covering Lead Product For Alcohol Use Disorder
Adial Pharmaceuticals strengthens its patent portfolio with the issuance of a new US patent covering AD04's potential for treating opioid use disorder through targeting the serotonin transporter gene. 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
EXCLUSIVE: Adial Pharmaceuticals Announces New US Patent Covering Its Molecular Genetic Diagnosing For Alcohol, Drug Dependence
Adial Pharmaceuticals US patent, enhancing genetic diagnostic coverage for tailored treatment of alcohol and drug dependencies, including opioid use disorder. Learn more about AD04's potential in... 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.